 | • レポートコード：QAF27597 • 出版社/出版日：QYResearch / 2021年3月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のブデソニド市場について種類別（注射用懸濁液、エアロゾル、吸入粉末、錠剤＆カプセル）、用途別（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ブデソニド市場の概要 ・世界の主要地域別ブデソニド市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のブデソニド市場規模2016-2021：種類別（注射用懸濁液、エアロゾル、吸入粉末、錠剤＆カプセル） ・世界のブデソニド市場予測2012-2027：種類別（注射用懸濁液、エアロゾル、吸入粉末、錠剤＆カプセル） ・世界のブデソニド市場規模2016-2021：用途別（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他） ・世界のブデソニド市場予測2012-2027：用途別（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他） ・ブデソニドのアメリカ市場規模と予測2016-2021 ・ブデソニドのヨーロッパ市場規模と予測2016-2021 ・ブデソニドの中国市場規模と予測2016-2021 ・ブデソニドの日本市場規模と予測2016-2021 ・ブデソニドの東南アジア市場規模と予測2016-2021 ・ブデソニドのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca、Teva、Mylan、Sandoz、Cosmo Pharmaceuticals、Salix、Chiesi Farmaceutici、Orion Corporation、Cipla、Synmosa Biopharma、Lunan Better Pharma、Shanghai Sine Promod） ・ブデソニドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ブデソニドの市場動向・機会・課題 ・調査の結論 |
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn’s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
The industry’s leading manufacturers are AstraZeneca and Teva, with 52.93% and 16.78% of revenue, respectively. By region, North America has the highest share of income, at around 36.5% in 2019.
Market Analysis and Insights: Global Budesonide Market
The global Budesonide market was valued at US$ 8339.3 in 2020 and will reach US$ 10130 million by the end of 2027, growing at a CAGR of 3.3% during 2022-2027.
Global Budesonide Scope and Market Size
The global Budesonide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
The Budesonide market is analysed and market size information is provided by regions (countries). Segment by Application, the Budesonide market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
1 Budesonide Market Overview
1.1 Budesonide Product Scope
1.2 Budesonide Segment by Type
1.2.1 Global Budesonide Sales by Type (2016 & 2021 & 2027)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide Segment by Application
1.3.1 Global Budesonide Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Budesonide Market Estimates and Forecasts (2016-2027)
1.4.1 Global Budesonide Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Budesonide Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Budesonide Price Trends (2016-2027)
2 Budesonide Estimates and Forecasts by Region
2.1 Global Budesonide Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Budesonide Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Budesonide Sales Market Share by Region (2016-2021)
2.2.2 Global Budesonide Revenue Market Share by Region (2016-2021)
2.3 Global Budesonide Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Budesonide Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Budesonide Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Budesonide Estimates and Projections (2016-2027)
2.4.2 Europe Budesonide Estimates and Projections (2016-2027)
2.4.3 China Budesonide Estimates and Projections (2016-2027)
2.4.4 Japan Budesonide Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Budesonide Estimates and Projections (2016-2027)
2.4.6 India Budesonide Estimates and Projections (2016-2027)
3 Global Budesonide Competition Landscape by Players
3.1 Global Top Budesonide Players by Sales (2016-2021)
3.2 Global Top Budesonide Players by Revenue (2016-2021)
3.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Budesonide as of 2020)
3.4 Global Budesonide Average Price by Company (2016-2021)
3.5 Manufacturers Budesonide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Budesonide Market Size by Type
4.1 Global Budesonide Historic Market Review by Type (2016-2021)
4.1.1 Global Budesonide Sales Market Share by Type (2016-2021)
4.1.2 Global Budesonide Revenue Market Share by Type (2016-2021)
4.1.3 Global Budesonide Price by Type (2016-2021)
4.2 Global Budesonide Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Budesonide Sales Forecast by Type (2022-2027)
4.2.2 Global Budesonide Revenue Forecast by Type (2022-2027)
4.2.3 Global Budesonide Price Forecast by Type (2022-2027)
5 Global Budesonide Market Size by Application
5.1 Global Budesonide Historic Market Review by Application (2016-2021)
5.1.1 Global Budesonide Sales Market Share by Application (2016-2021)
5.1.2 Global Budesonide Revenue Market Share by Application (2016-2021)
5.1.3 Global Budesonide Price by Application (2016-2021)
5.2 Global Budesonide Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Budesonide Sales Forecast by Application (2022-2027)
5.2.2 Global Budesonide Revenue Forecast by Application (2022-2027)
5.2.3 Global Budesonide Price Forecast by Application (2022-2027)
6 North America Budesonide Market Facts & Figures
6.1 North America Budesonide Sales by Company
6.1.1 North America Budesonide Sales by Company (2016-2021)
6.1.2 North America Budesonide Revenue by Company (2016-2021)
6.2 North America Budesonide Sales Breakdown by Type
6.2.1 North America Budesonide Sales Breakdown by Type (2016-2021)
6.2.2 North America Budesonide Sales Breakdown by Type (2022-2027)
6.3 North America Budesonide Sales Breakdown by Application
6.3.1 North America Budesonide Sales Breakdown by Application (2016-2021)
6.3.2 North America Budesonide Sales Breakdown by Application (2022-2027)
7 Europe Budesonide Market Facts & Figures
7.1 Europe Budesonide Sales by Company
7.1.1 Europe Budesonide Sales by Company (2016-2021)
7.1.2 Europe Budesonide Revenue by Company (2016-2021)
7.2 Europe Budesonide Sales Breakdown by Type
7.2.1 Europe Budesonide Sales Breakdown by Type (2016-2021)
7.2.2 Europe Budesonide Sales Breakdown by Type (2022-2027)
7.3 Europe Budesonide Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Budesonide Market Facts & Figures
8.1 China Budesonide Sales by Company
8.1.1 China Budesonide Sales by Company (2016-2021)
8.1.2 China Budesonide Revenue by Company (2016-2021)
8.2 China Budesonide Sales Breakdown by Type
8.2.1 China Budesonide Sales Breakdown by Type (2016-2021)
8.2.2 China Budesonide Sales Breakdown by Type (2022-2027)
8.3 China Budesonide Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Budesonide Market Facts & Figures
9.1 Japan Budesonide Sales by Company
9.1.1 Japan Budesonide Sales by Company (2016-2021)
9.1.2 Japan Budesonide Revenue by Company (2016-2021)
9.2 Japan Budesonide Sales Breakdown by Type
9.2.1 Japan Budesonide Sales Breakdown by Type (2016-2021)
9.2.2 Japan Budesonide Sales Breakdown by Type (2022-2027)
9.3 Japan Budesonide Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Budesonide Market Facts & Figures
10.1 Southeast Asia Budesonide Sales by Company
10.1.1 Southeast Asia Budesonide Sales by Company (2016-2021)
10.1.2 Southeast Asia Budesonide Revenue by Company (2016-2021)
10.2 Southeast Asia Budesonide Sales Breakdown by Type
10.2.1 Southeast Asia Budesonide Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Budesonide Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Budesonide Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Budesonide Market Facts & Figures
11.1 India Budesonide Sales by Company
11.1.1 India Budesonide Sales by Company (2016-2021)
11.1.2 India Budesonide Revenue by Company (2016-2021)
11.2 India Budesonide Sales Breakdown by Type
11.2.1 India Budesonide Sales Breakdown by Type (2016-2021)
11.2.2 India Budesonide Sales Breakdown by Type (2022-2027)
11.3 India Budesonide Sales Breakdown by Application
11.3.1 India Budesonide Sales Breakdown by Application (2016-2021)
11.3.2 India Budesonide Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Budesonide Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Budesonide Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Budesonide Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Budesonide Products Offered
12.3.5 Mylan Recent Development
12.4 Sandoz
12.4.1 Sandoz Corporation Information
12.4.2 Sandoz Business Overview
12.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sandoz Budesonide Products Offered
12.4.5 Sandoz Recent Development
12.5 Cosmo Pharmaceuticals
12.5.1 Cosmo Pharmaceuticals Corporation Information
12.5.2 Cosmo Pharmaceuticals Business Overview
12.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cosmo Pharmaceuticals Budesonide Products Offered
12.5.5 Cosmo Pharmaceuticals Recent Development
12.6 Salix
12.6.1 Salix Corporation Information
12.6.2 Salix Business Overview
12.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Salix Budesonide Products Offered
12.6.5 Salix Recent Development
12.7 Chiesi Farmaceutici
12.7.1 Chiesi Farmaceutici Corporation Information
12.7.2 Chiesi Farmaceutici Business Overview
12.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chiesi Farmaceutici Budesonide Products Offered
12.7.5 Chiesi Farmaceutici Recent Development
12.8 Orion Corporation
12.8.1 Orion Corporation Corporation Information
12.8.2 Orion Corporation Business Overview
12.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Orion Corporation Budesonide Products Offered
12.8.5 Orion Corporation Recent Development
12.9 Cipla
12.9.1 Cipla Corporation Information
12.9.2 Cipla Business Overview
12.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Cipla Budesonide Products Offered
12.9.5 Cipla Recent Development
12.10 Synmosa Biopharma
12.10.1 Synmosa Biopharma Corporation Information
12.10.2 Synmosa Biopharma Business Overview
12.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Synmosa Biopharma Budesonide Products Offered
12.10.5 Synmosa Biopharma Recent Development
12.11 Lunan Better Pharma
12.11.1 Lunan Better Pharma Corporation Information
12.11.2 Lunan Better Pharma Business Overview
12.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lunan Better Pharma Budesonide Products Offered
12.11.5 Lunan Better Pharma Recent Development
12.12 Shanghai Sine Promod
12.12.1 Shanghai Sine Promod Corporation Information
12.12.2 Shanghai Sine Promod Business Overview
12.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shanghai Sine Promod Budesonide Products Offered
12.12.5 Shanghai Sine Promod Recent Development
13 Budesonide Manufacturing Cost Analysis
13.1 Budesonide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Budesonide
13.4 Budesonide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Budesonide Distributors List
14.3 Budesonide Customers
15 Market Dynamics
15.1 Budesonide Market Trends
15.2 Budesonide Drivers
15.3 Budesonide Market Challenges
15.4 Budesonide Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Budesonide Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Budesonide Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Budesonide Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Budesonide Sales (M Units) by Region (2016-2021)
Table 5. Global Budesonide Sales Market Share by Region (2016-2021)
Table 6. Global Budesonide Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Budesonide Revenue Share by Region (2016-2021)
Table 8. Global Budesonide Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Budesonide Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Budesonide Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Budesonide Revenue Share Forecast by Region (2022-2027)
Table 12. Global Budesonide Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Budesonide Sales Share by Company (2016-2021)
Table 14. Global Budesonide Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Budesonide Revenue Share by Company (2016-2021)
Table 16. Global Budesonide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2020)
Table 17. Global Budesonide Average Price (US$/K Units) of Key Company (2016-2021)
Table 18. Manufacturers Budesonide Manufacturing Sites and Area Served
Table 19. Manufacturers Budesonide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Budesonide Sales (M Units) by Type (2016-2021)
Table 22. Global Budesonide Sales Share by Type (2016-2021)
Table 23. Global Budesonide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Budesonide Price (US$/K Units) by Type (2016-2021)
Table 25. Global Budesonide Sales Share by Type (2022-2027)
Table 26. Global Budesonide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Budesonide Revenue Share by Type (2022-2027)
Table 28. Global Budesonide Price (US$/K Units) by Type (2022-2027)
Table 29. Global Budesonide Sales (M Units) by Application (2016-2021)
Table 30. Global Budesonide Sales Share by Application (2016-2021)
Table 31. Global Budesonide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Budesonide Price (US$/K Units) by Application (2016-2021)
Table 33. Global Budesonide Sales (M Units) by Application (2022-2027)
Table 34. Global Budesonide Sales Share by Application (2022-2027)
Table 35. Global Budesonide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Budesonide Revenue Share by Application (2022-2027)
Table 37. Global Budesonide Price (US$/K Units) by Application (2022-2027)
Table 38. North America Budesonide Sales (M Units) by Company (2016-2021)
Table 39. North America Budesonide Sales Market Share by Company (2016-2021)
Table 40. North America Budesonide Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Budesonide Revenue Market Share by Company (2016-2021)
Table 42. North America Budesonide Sales by Type (2016-2021) & (M Units)
Table 43. North America Budesonide Sales Market Share by Type (2016-2021)
Table 44. North America Budesonide Sales by Type (2022-2027) & (M Units)
Table 45. North America Budesonide Sales Market Share by Type (2022-2027)
Table 46. North America Budesonide Sales by Application (2016-2021) & (M Units)
Table 47. North America Budesonide Sales Market Share by Application (2016-2021)
Table 48. North America Budesonide Sales by Application (2022-2027) & (M Units)
Table 49. North America Budesonide Sales Market Share by Application (2022-2027)
Table 50. Europe Budesonide Sales (M Units) by Company (2016-2021)
Table 51. Europe Budesonide Sales Market Share by Company (2016-2021)
Table 52. Europe Budesonide Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Budesonide Revenue Market Share by Company (2016-2021)
Table 54. Europe Budesonide Sales by Type (2016-2021) & (M Units)
Table 55. Europe Budesonide Sales Market Share by Type (2016-2021)
Table 56. Europe Budesonide Sales by Type (2022-2027) & (M Units)
Table 57. Europe Budesonide Sales Market Share by Type (2022-2027)
Table 58. Europe Budesonide Sales by Application (2016-2021) & (M Units)
Table 59. Europe Budesonide Sales Market Share by Application (2016-2021)
Table 60. Europe Budesonide Sales by Application (2022-2027) & (M Units)
Table 61. Europe Budesonide Sales Market Share by Application (2022-2027)
Table 62. China Budesonide Sales (M Units) by Company (2016-2021)
Table 63. China Budesonide Sales Market Share by Company (2016-2021)
Table 64. China Budesonide Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Budesonide Revenue Market Share by Company (2016-2021)
Table 66. China Budesonide Sales by Type (2016-2021) & (M Units)
Table 67. China Budesonide Sales Market Share by Type (2016-2021)
Table 68. China Budesonide Sales by Type (2022-2027) & (M Units)
Table 69. China Budesonide Sales Market Share by Type (2022-2027)
Table 70. China Budesonide Sales by Application (2016-2021) & (M Units)
Table 71. China Budesonide Sales Market Share by Application (2016-2021)
Table 72. China Budesonide Sales by Application (2022-2027) & (M Units)
Table 73. China Budesonide Sales Market Share by Application (2022-2027)
Table 74. Japan Budesonide Sales (M Units) by Company (2016-2021)
Table 75. Japan Budesonide Sales Market Share by Company (2016-2021)
Table 76. Japan Budesonide Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Budesonide Revenue Market Share by Company (2016-2021)
Table 78. Japan Budesonide Sales by Type (2016-2021) & (M Units)
Table 79. Japan Budesonide Sales Market Share by Type (2016-2021)
Table 80. Japan Budesonide Sales by Type (2022-2027) & (M Units)
Table 81. Japan Budesonide Sales Market Share by Type (2022-2027)
Table 82. Japan Budesonide Sales by Application (2016-2021) & (M Units)
Table 83. Japan Budesonide Sales Market Share by Application (2016-2021)
Table 84. Japan Budesonide Sales by Application (2022-2027) & (M Units)
Table 85. Japan Budesonide Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Budesonide Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Budesonide Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Budesonide Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Budesonide Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Budesonide Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Budesonide Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Budesonide Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Budesonide Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Budesonide Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Budesonide Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Budesonide Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Budesonide Sales Market Share by Application (2022-2027)
Table 98. India Budesonide Sales (M Units) by Company (2016-2021)
Table 99. India Budesonide Sales Market Share by Company (2016-2021)
Table 100. India Budesonide Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Budesonide Revenue Market Share by Company (2016-2021)
Table 102. India Budesonide Sales by Type (2016-2021) & (M Units)
Table 103. India Budesonide Sales Market Share by Type (2016-2021)
Table 104. India Budesonide Sales by Type (2022-2027) & (M Units)
Table 105. India Budesonide Sales Market Share by Type (2022-2027)
Table 106. India Budesonide Sales by Application (2016-2021) & (M Units)
Table 107. India Budesonide Sales Market Share by Application (2016-2021)
Table 108. India Budesonide Sales by Application (2022-2027) & (M Units)
Table 109. India Budesonide Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 113. AstraZeneca Budesonide Product
Table 114. AstraZeneca Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Description and Business Overview
Table 117. Teva Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 118. Teva Budesonide Product
Table 119. Teva Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 123. Mylan Budesonide Product
Table 124. Mylan Recent Development
Table 125. Sandoz Corporation Information
Table 126. Sandoz Description and Business Overview
Table 127. Sandoz Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 128. Sandoz Budesonide Product
Table 129. Sandoz Recent Development
Table 130. Cosmo Pharmaceuticals Corporation Information
Table 131. Cosmo Pharmaceuticals Description and Business Overview
Table 132. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 133. Cosmo Pharmaceuticals Budesonide Product
Table 134. Cosmo Pharmaceuticals Recent Development
Table 135. Salix Corporation Information
Table 136. Salix Description and Business Overview
Table 137. Salix Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 138. Salix Budesonide Product
Table 139. Salix Recent Development
Table 140. Chiesi Farmaceutici Corporation Information
Table 141. Chiesi Farmaceutici Description and Business Overview
Table 142. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 143. Chiesi Farmaceutici Budesonide Product
Table 144. Chiesi Farmaceutici Recent Development
Table 145. Orion Corporation Corporation Information
Table 146. Orion Corporation Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 147. Orion Corporation Description and Business Overview
Table 148. Orion Corporation Budesonide Product
Table 149. Orion Corporation Recent Development
Table 150. Cipla Corporation Information
Table 151. Cipla Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 152. Cipla Description and Business Overview
Table 153. Cipla Budesonide Product
Table 154. Cipla Recent Development
Table 155. Synmosa Biopharma Corporation Information
Table 156. Synmosa Biopharma Description and Business Overview
Table 157. Synmosa Biopharma Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 158. Synmosa Biopharma Budesonide Product
Table 159. Synmosa Biopharma Recent Development
Table 160. Lunan Better Pharma Corporation Information
Table 161. Lunan Better Pharma Description and Business Overview
Table 162. Lunan Better Pharma Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 163. Lunan Better Pharma Budesonide Product
Table 164. Lunan Better Pharma Recent Development
Table 165. Shanghai Sine Promod Corporation Information
Table 166. Shanghai Sine Promod Description and Business Overview
Table 167. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2016-2021)
Table 168. Shanghai Sine Promod Budesonide Product
Table 169. Shanghai Sine Promod Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Budesonide Distributors List
Table 173. Budesonide Customers List
Table 174. Budesonide Market Trends
Table 175. Budesonide Market Drivers
Table 176. Budesonide Market Challenges
Table 177. Budesonide Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Budesonide Sales Market Share by Application in 2021 & 2027
Figure 6. Respiratory Disease Treatment Examples
Figure 7. Nose Disease Treatment Examples
Figure 8. Inflammatory Bowel Disease Treatment Examples
Figure 9. Others Examples
Figure 10. Global Budesonide Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Budesonide Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Budesonide Sales (M Units) Growth Rate (2016-2027)
Figure 13. Global Budesonide Price Trends Growth Rate (2016-2027) (US$/K Units)
Figure 14. Global Budesonide Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Budesonide Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Budesonide Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Budesonide Sales (M Units) Growth Rate (2016-2027)
Figure 18. Europe Budesonide Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Budesonide Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Budesonide Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Budesonide Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Budesonide Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Budesonide Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Budesonide Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Budesonide Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Budesonide Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Budesonide Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Budesonide Players Market Share by Revenue in Budesonide: 2016 & 2020
Figure 29. Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Budesonide Revenue Share by Type (2016-2021)
Figure 31. Global Budesonide Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Budesonide Revenue Share by Application (2016-2021)
Figure 33. Global Budesonide Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Budesonide Sales Market Share by Type in 2020
Figure 35. North America Budesonide Sales Market Share by Application in 2020
Figure 36. Europe Budesonide Sales Market Share by Type in 2020
Figure 37. Europe Budesonide Sales Market Share by Application in 2020
Figure 38. China Budesonide Sales Market Share by Type in 2020
Figure 39. China Budesonide Sales Market Share by Application in 2020
Figure 40. Japan Budesonide Sales Market Share by Type in 2020
Figure 41. Japan Budesonide Sales Market Share by Application in 2020
Figure 42. Southeast Asia Budesonide Sales Market Share by Type in 2020
Figure 43. Southeast Asia Budesonide Sales Market Share by Application in 2020
Figure 44. India Budesonide Sales Market Share by Type in 2020
Figure 45. India Budesonide Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Budesonide
Figure 48. Manufacturing Process Analysis of Budesonide
Figure 49. Budesonide Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
ブデソニド（BUD）のグローバル市場調査 2019年 The global Budesonide (BUD) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Budesonide (BUD) volume and value at global level, regional level and company level. From a global perspective, this repor…- 炎症性腸疾患治療のグローバル市場調査 2019年 The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company leve…
- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
- 世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …